← Open Payments lookup

MILAJURINE LINDSAY: Open Payments

NPI 1003958208 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,936 in 69 payments from 31 companies in 2025. Trend: 2023 $850 · 2024 $1,893 · 2025 $2,936

Food & beverage: $2,936
CompanyPaymentsAmount
AOP Health US, LLC1$695
Medtronic, Inc.10$426
CeQur Corporation1$289
Novo Nordisk Inc11$256
Bayer Healthcare Pharmaceuticals Inc.1$145
Insulet Corporation1$104
BETA BIONICS, INC.1$103
Tandem Diabetes Care, Inc.4$100
Lilly USA, LLC4$85
Corcept Therapeutics4$73

Products named: Rapiblyk, MINIMED 780G, CeQur Simplicity, Kerendia, Ozempic, OMNIPOD, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ.

Industry payments across DC — which companies pay providers there.